Latest News & Updates
Breaking News
22 hours ago
Vaibhavi M.
Other trending news you may like to read
SpyGlass Pharma Appoints Shannon Treviño as General Counsel Ahead of BIM-IOL Phase 3 Completion
SpyGlass Pharma names Shannon Treviño as General Counsel as BIM-IOL Phase 3 trials enroll and an NDA submission moves closer.
Vaibhavi M.
Betterbrand Positions BetterLungs Supplement for Respiratory Support Amid 2026 Wildfire Season
Betterbrand markets BetterLungs for wildfire smoke exposure as 2026 AQI levels exceed safe thresholds across multiple U.S. regions.
Vaibhavi M.
FDA Reaffirms Import Requirements for Human Drugs Under FD&C Act and 21 CFR
FDA consolidates human drug import requirements under FD&C Act and 21 CFR, covering CGMP, establishment registration, labeling, and API compliance.
Vaibhavi M.
FDA Finalizes PLAIR Guidance, Setting Import Windows for Pre-Approval Drug Launches
FDA's final PLAIR guidance sets 60- and 120-day import windows for pre-approval finished drugs, with submission routed through the CDER NexGen Portal.
Vaibhavi M.
